Karamitsos, K.; Oikonomou, E.; Theofilis, P.; Ikonomidis, I.; Kassi, E.; Lambadiari, V.; Gialafos, E.; Tsatsaragkou, A.; Mystakidi, V.-C.; Zisimos, K.;
et al. The Role of NLRP3 Inflammasome in Type 2 Diabetes Mellitus and Its Macrovascular Complications. J. Clin. Med. 2025, 14, 4606.
https://doi.org/10.3390/jcm14134606
AMA Style
Karamitsos K, Oikonomou E, Theofilis P, Ikonomidis I, Kassi E, Lambadiari V, Gialafos E, Tsatsaragkou A, Mystakidi V-C, Zisimos K,
et al. The Role of NLRP3 Inflammasome in Type 2 Diabetes Mellitus and Its Macrovascular Complications. Journal of Clinical Medicine. 2025; 14(13):4606.
https://doi.org/10.3390/jcm14134606
Chicago/Turabian Style
Karamitsos, Konstantinos, Evangelos Oikonomou, Panagiotis Theofilis, Ignatios Ikonomidis, Eva Kassi, Vaia Lambadiari, Elias Gialafos, Aikaterini Tsatsaragkou, Vasiliki-Chara Mystakidi, Konstantinos Zisimos,
and et al. 2025. "The Role of NLRP3 Inflammasome in Type 2 Diabetes Mellitus and Its Macrovascular Complications" Journal of Clinical Medicine 14, no. 13: 4606.
https://doi.org/10.3390/jcm14134606
APA Style
Karamitsos, K., Oikonomou, E., Theofilis, P., Ikonomidis, I., Kassi, E., Lambadiari, V., Gialafos, E., Tsatsaragkou, A., Mystakidi, V.-C., Zisimos, K., Dimitriadis, K., Tousoulis, D., & Siasos, G.
(2025). The Role of NLRP3 Inflammasome in Type 2 Diabetes Mellitus and Its Macrovascular Complications. Journal of Clinical Medicine, 14(13), 4606.
https://doi.org/10.3390/jcm14134606
